Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Florida Cancer Specialists
mi
from
Fort Myers, FL
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Mountain States Tumor Institute
mi
from
Boise, ID
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Mountain States Tumor Institute
mi
from
Boise, ID
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Mountain States Tumor Institute
mi
from
Fruitland, ID
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Mountain States Tumor Institute
mi
from
Fruitland, ID
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Mountain States Tumor Institute
mi
from
Meridian, ID
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Mountain States Tumor Institute
mi
from
Meridian, ID
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Mountain States Tumor Institute
mi
from
Nampa, ID
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Mountain States Tumor Institute
mi
from
Nampa, ID
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Mountain States Tumor Institute
mi
from
Twin Falls, ID
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Mountain States Tumor Institute
mi
from
Twin Falls, ID
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital
mi
from
New Lenox, IL
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital
mi
from
New Lenox, IL
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Indiana University - Wishard Hospital
mi
from
Indianapolis, IN
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Indiana University - Wishard Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Indiana University - Springmill Medical Clinic
mi
from
Indianapolis, IN
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Indiana University - Springmill Medical Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Eastern Maine Medical Center's Cancer Care
mi
from
Brewer, ME
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Eastern Maine Medical Center's Cancer Care
mi
from
Brewer, ME
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins - Green Spring Station
mi
from
Lutherville, MD
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins - Green Spring Station
mi
from
Lutherville, MD
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Mass General/North Shore Cancer Center
mi
from
Danvers, MA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Mass General/North Shore Cancer Center
mi
from
Danvers, MA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Lowell General Hospital
mi
from
Lowell, MA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Lowell General Hospital
mi
from
Lowell, MA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute at Milford Hospital
mi
from
Milford, MA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute at Milford Hospital
mi
from
Milford, MA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Univeristy of Michigan Health System
mi
from
Ann Arbor, MI
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Univeristy of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
New Hampshire Oncology-Hematology, PA
mi
from
Concord, NH
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
New Hampshire Oncology-Hematology, PA
mi
from
Concord, NH
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
New Hampshire Oncology-Hematology PA
mi
from
Hooksett, NH
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
New Hampshire Oncology-Hematology PA
mi
from
Hooksett, NH
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
New Hampshire Oncology-Hematology, PA
mi
from
Laconia, NH
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
New Hampshire Oncology-Hematology, PA
mi
from
Laconia, NH
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Insitute at Londonderry Hospital
mi
from
Londonderry, NH
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Insitute at Londonderry Hospital
mi
from
Londonderry, NH
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan-Kettering Cancer Center - Basking Ridge
mi
from
Basking Ridge, NJ
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center - Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Queens Hospital Center, Comprehensive Cancer Center
mi
from
Jamaica, NY
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Queens Hospital Center, Comprehensive Cancer Center
mi
from
Jamaica, NY
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
North Shore-LIJ Health System Monter Cancer Center
mi
from
Lake Success, NY
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
North Shore-LIJ Health System Monter Cancer Center
mi
from
Lake Success, NY
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan-Kettering Cancer Center at Mercy
mi
from
Rockville Centre, NY
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center at Mercy
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan-Kettering Cancer Center Sleepy Hollow
mi
from
Sleepy Hollow, NY
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan-Kettering Cancer Center Sleepy Hollow
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Rex Cancer Center
mi
from
Raleigh, NC
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Rex Cancer Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC/HVHS Cancer Center, UPMC Beaver
mi
from
Beaver, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC/HVHS Cancer Center, UPMC Beaver
mi
from
Beaver, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC Horizon (Shenango)
mi
from
Farrell, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC Horizon (Shenango)
mi
from
Farrell, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Arnold Palmer Cancer Center-Greensburg
mi
from
Greensburg, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Cancer Center-Greensburg
mi
from
Greensburg, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC Horizon (Greenville)
mi
from
Greenville, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC Horizon (Greenville)
mi
from
Greenville, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC Cancer Center Jefferson Regional Med Ctr
mi
from
Jefferson Hills, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC Cancer Center Jefferson Regional Med Ctr
mi
from
Jefferson Hills, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC Conemaugh Cancer Center
mi
from
Johnstown, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC Conemaugh Cancer Center
mi
from
Johnstown, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC McKeesport
mi
from
McKeesport, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC McKeesport
mi
from
McKeesport, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC East
mi
from
Monroeville, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC East
mi
from
Monroeville, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
Arnold Palmer Medical Oncology-Mt Pleasant
mi
from
Mount Pleasant, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Medical Oncology-Mt Pleasant
mi
from
Mount Pleasant, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC Jameson Cancer Center
mi
from
New Castle, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC Jameson Cancer Center
mi
from
New Castle, PA
Click here to add this to my saved trials
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated:  12/31/1969
UPMC St. Margaret
mi
from
Pittsburgh, PA
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
A Randomized Phase II Study of Trastuzumab Emtansine (T-DM1) vs. Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT Trial)
Status: Enrolling
Updated: 12/31/1969
UPMC St. Margaret
mi
from
Pittsburgh, PA
Click here to add this to my saved trials